Valsartan Related Compound C
(N-VALERYL-N-{[2�?(1HTETRAZOLE-5-YL)BIPHENYL-4-YL]METHYL}-L-VALINEBENZYL ESTER)
( S)- N-Valeryl- N-([2�?(1 H-tetrazole-5-yl)-biphenyl-4-yl]methyl)valine benzyl ester
N-(1-Oxopentyl)- N-[[2�?(2 H-tetrazol-5-yl)[1,1�?biphenyl]-4-yl]methyl]- L -valine phenylmethyl ester
缬沙坦相关化合物C

产品介绍９�/div>

产品说明

一般描�?/p>

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance withISO 17034andISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAC3176 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子弎�/td>	C31H35N5O3
分子野�/td>	525.64
MDL编号	MFCD12407184
NACRES	NA.24

产品性质

质量水平	300
等级	certified reference material pharmaceutical secondary standard
形式	solid
CofA	current certificate can be downloaded
包装	pkg of 30 mg
药典可追溯�?/td>	traceable to USP 1708795
储存温度	2-8ℂ�/td>
SMILES string	CCCCC(=O)N(Cc1ccc(cc1)-c2ccccc2-c3nnn[nH]3)[C@@H](C(C)C)C(=O)OCc4ccccc4
InChI	1S/C31H35N5O3/c1-4-5-15-28(37)36(29(22(2)3)31(38)39-21-24-11-7-6-8-12-24)20-23-16-18-25(19-17-23)26-13-9-10-14-27(26)30-32-34-35-33-30/h6-14,16-19,22,29H,4-5,15,20-21H2,1-3H3,(H,32,33,34,35)/t29-/m0/s1
InChI key	VXKKFWDUSKMRNO-LJAQVGFWSA-N

安全信息

象形国�/td>
警示用语９�/td>	Warning
危险声明	H302 - H410
预防措施声明	P264 - P270 - P273 - P301 + P312 - P391 - P501
危险分类	Acute Tox. 4 Oral - Aquatic Chronic 1
储存分类代码	13 - Non Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable